NCT02023346View on ClinicalTrials.gov

Prognostic Awareness and Patient-Physician Communication in Malignant Glioma

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2018

Conditions
Malignant Glioma
Interventions
BEHAVIORAL

surveys and cognitive tests

Trial Locations (1)

10065

Memoral Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02023346 - Prognostic Awareness and Patient-Physician Communication in Malignant Glioma | Biotech Hunter | Biotech Hunter